Myelofibrosis treatment with imetelstat led to remission for some patients in small study
(dailyRx News) Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.
These researchers found that some patients treated with imetelstat had complete bone marrow recovery, allowing them to once again make their own red blood cells.
This study also showed a promising rate of partial remission, a period where symptoms improve or the affected area becomes smaller.
Read more from RxWiki HERE.
Posted in Industry News, News